These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7816977)

  • 21. Estrogens are indicated for the prevention of coronary artery disease: a debate for estrogen.
    Leiter LA
    Can J Cardiol; 2000 Aug; 16 Suppl E():13E-16E. PubMed ID: 10906619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
    Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lifetime physical activity and breast cancer risk in pre- and postmenopausal women.
    Dorn J; Vena J; Brasure J; Freudenheim J; Graham S
    Med Sci Sports Exerc; 2003 Feb; 35(2):278-85. PubMed ID: 12569217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Bezemer ID; Rinaldi S; Dossus L; Gils CH; Peeters PH; Noord PA; Bueno-de-Mesquita HB; Johnsen SP; Overvad K; Olsen A; Tjønneland A; Boeing H; Lahmann PH; Linseisen J; Nagel G; Allen N; Roddam A; Bingham S; Khaw KT; Kesse E; Téhard B; Clavel-Chapelon F; Agudo A; Ardanaz E; Quiros JR; Amiano P; Martínez-Garcia C; Tormo MJ; Pala V; Panico S; Vineis P; Palli D; Tumino R; Trichopoulou A; Baibas N; Zilis D; Hémon B; Norat T; Riboli E; Kaaks R
    Cancer Causes Control; 2005 Jun; 16(5):561-72. PubMed ID: 15986111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypercholesterolemia: when and how much to treat it?].
    Carmena R
    Med Clin (Barc); 1983 Feb; 80(6):261-2. PubMed ID: 6865558
    [No Abstract]   [Full Text] [Related]  

  • 26. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
    Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
    Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endocrinological changes in pre- and postmenopause].
    von Holst T
    Ther Umsch; 1994 Nov; 51(11):722-8. PubMed ID: 7839330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary prevention in hypercholesterolemia. High HDL cholesterol levels and female gender underestimated protective factors].
    Wahlberg G
    Lakartidningen; 2006 Jan 18-24; 103(3):131-4. PubMed ID: 16465756
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of estrogen plus progestin treatment on sleep: a randomized, placebo-controlled, double-blind trial in premenopausal and late postmenopausal women.
    Kalleinen N; Polo O; Himanen SL; Joutsen A; Polo-Kantola P
    Climacteric; 2008 Jun; 11(3):233-43. PubMed ID: 18568788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Disordered lipid metabolism--current diagnostics].
    Schwandt P
    MMW Fortschr Med; 2003 Mar; 145(13):26-7. PubMed ID: 15101528
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study of the action of hypolipemic and antioxidant drugs in ischemic heart disease].
    Kalmykova VI; Nikitina EK; Bezzubov AA
    Sov Med; 1986; (3):81-4. PubMed ID: 3520867
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of hypolipemic agents on levels of total plasma homocysteine].
    Dvoráková J; Dubská L; Táborský L; Hyánek J
    Vnitr Lek; 2001 Oct; 47(10):674-7. PubMed ID: 11789004
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of left ventricular hypertrophy expression in patients with hypertrophic cardiomyopathy on the basis of sex.
    Dimitrow PP; Czarnecka D; Jaszcz KK; Dubiel JS
    J Cardiovasc Risk; 1998 Apr; 5(2):85-7. PubMed ID: 9821060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Policosanol: a new treatment for cardiovascular disease?
    Janikula M
    Altern Med Rev; 2002 Jun; 7(3):203-17. PubMed ID: 12126462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controversial aspects of hormone replacement therapy upon cardiovascular mortality and morbidity of women in menopause.
    Rosano GM; Mercuro G
    G Ital Cardiol; 1999 Sep; 29(9):999-1003. PubMed ID: 10514956
    [No Abstract]   [Full Text] [Related]  

  • 38. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
    Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of pretreatment attrition from smoking cessation among pre- and postmenopausal, weight-concerned women.
    Copeland AL; Martin PD; Geiselman PJ; Rash CJ; Kendzor DE
    Eat Behav; 2006 Aug; 7(3):243-51. PubMed ID: 16843227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome.
    Cho GJ; Lee JH; Park HT; Shin JH; Hong SC; Kim T; Hur JY; Lee KW; Park YK; Kim SH
    Menopause; 2008; 15(3):524-9. PubMed ID: 18467953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.